Health Sciences Public Relations and Marketing

Rebels Home Main Image

Technology and entertainment moguls headline most successful fund-raising event for USC center for cancer research – $9 million raised in one night

Oracle co-founder/CEO Larry Ellison and Paramount Pictures CEO Brad Grey team with Keck School of Medicine Dean Carmen Puliafito and renowned cancer researcher Dr. David Agus at Rebels With a Cause event benefitting USC Center for Applied Molecular Medicine for life-saving cancer research

Read The Full Story
Rebels Home Main Image

Technology and entertainment moguls headline most successful fund-raising event for USC center for cancer research – $9 million raised in one night

Oracle co-founder/CEO Larry Ellison and Paramount Pictures CEO Brad Grey team with Keck School of Medicine Dean Carmen Puliafito and renowned cancer researcher Dr. David Agus at Rebels With a Cause event benefitting USC Center for Applied Molecular Medicine for life-saving cancer research

Read The Full Story

Philanthropist supports cancer drug research with $500,000 gift

Philanthropist supports cancer drug research with $500,000 gift

Read The Full Story

Dean proclaims Match Day 2014 the best in Keck School history

Keck School students and their families and friends gathered in the Harry and Celeste Pappas Quad with their instructors to learn where they'll be going for their residencies.

Read The Full Story

Lasker Lecturers shed light on major breakthroughs

Keck School of Medicine of USC students and faculty gathered to learn more about genetic cancer therapy and neurotransmitter release in the brain at the 2014 Lasker Lectures Program.

Read The Full Story

Keck Medicine of USC research indicates measure of circulating tumor cells may be better predictor of prostate cancer survival than PSA test

New research by USC Norris Comprehensive Cancer Center scientists demonstrates that measuring circulating tumor cells (CTCs) – the cells that spread cancer through the body – may be a better predictor of patient survival than the prostate specific antigen (PSA).

Read The Full Story
University of Southern California University of Southern California
1